In unprecedented operations over Iran, Israeli fighter pilots are being prescribed anti-narcolepsy drugs to maintain alertness during missions that can last more than 34 hours, highlighting the extreme demands of modern aerial warfare.
According to military sources, some pilots have been given Modafinil, a stimulant that increases wakefulness and mitigates fatigue, to help manage the intense physical and mental strain of long-duration flights. Missions targeting Iranian infrastructure and leadership can involve multiple aerial refuelings, surveillance, and precision strikes, often keeping pilots airborne for an entire day. The drugs are prescribed selectively, used only under supervision, and intended to maintain alertness rather than enhance cognitive performance or create euphoria.
“The limiting factor is the crew,” said a military source familiar with the operations. “If they do have some chemical enhancements to keep the crew going, they can do that.” Israeli pilots face unique challenges compared with larger air forces like the U.S., which can rotate personnel more easily. The small size of Israel’s aircrew necessitates longer individual missions, making controlled use of stimulants a practical consideration.
The use of performance-enhancing drugs in combat is not new. During the Vietnam War, U.S. soldiers were supplied with amphetamines, often called “pep pills,” to remain alert during reconnaissance and ambush missions. In the Middle East, stimulants such as Captagon have been used by militants to sustain energy during prolonged combat operations. However, Modafinil differs significantly from these substances, acting primarily to maintain wakefulness without inducing euphoria or excessive stimulation.
The demands on pilots flying over Iran are extraordinary. Beyond flying at high speeds and coordinating complex formations, they must perform aerial refuelings in hostile airspace, track targets, and respond to real-time intelligence updates. Extended periods in the air without sleep can impair concentration, reaction times, and decision-making, and can even lead to microsleep, where the brain temporarily “switches off” for a few seconds — a dangerous condition during critical phases of flight. Dr. Uri Elkan, a sleep physician, explained that fatigue can cause pilots to fixate on one goal or instrument, neglecting broader situational awareness, which could prove fatal in combat.
The Israeli Air Force emphasized that the drugs are offered only to personnel who request them and that proper rest remains essential. A statement noted that while some aircrew use medications under supervision, the majority of army units do not, and operational performance is grounded in training, effort, and skill rather than chemical enhancement. The military also expressed caution in publicly acknowledging the practice, citing concerns that uncontrolled drug use by civilians could have severe health consequences.
Historically, Israel has relied on pharmacological support in aviation since the Yom Kippur War of 1973, though the controlled use of Modafinil represents a modern, medically supervised approach to combat fatigue. Pilots operating F-15s — considered the workhorse of Israel’s air force — are most likely to receive the drug due to the length and intensity of their missions, while shorter sorties or rotations do not require chemical assistance.
The revelation underscores the extreme pressures faced by modern combat pilots and the technological and physiological measures needed to sustain operations over long distances. As Israel continues to conduct operations against Iranian targets, ensuring pilot alertness remains a critical component of mission success and operational safety, reflecting the evolving realities of aerial warfare in the 21st century.
